![Polly Murphy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Polly Murphy
Director/Board Member at
ATEA PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 2026-05-30
Profile
Dr. Polly A. Murphy is a Chief Business Officer at Avadel Pharmaceuticals Plc, an Independent Director at Celcuity, Inc. and an Independent Director at Atea Pharmaceuticals, Inc. She is on the Board of Directors at Celcuity, Inc. and Atea Pharmaceuticals, Inc. Dr. Murphy was previously employed as a Chief Business Officer by UroGen Pharma Ltd., a Vice President-Commercial Development by Pfizer Inc., and a Senior VP-Business & Scientific Services by The Scripps Research Institute.
She received her MBA from Nova Southeastern University, Inc. and a doctorate degree from Iowa State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CELCUITY INC. 0.01% | 2026-06-09 | 5,000 ( 0.01% ) | 664 400 $ | 2026-05-30 |
| 2026-06-17 | 121,745 ( 0.15% ) | 568 549 $ | 2026-05-30 |
Polly Murphy active positions
| Companies | Position | Start |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Director/Board Member | 2020-07-31 |
| CELCUITY INC. | Director/Board Member | 2022-09-11 |
| AVADEL PHARMACEUTICALS PLC | Corporate Officer/Principal | 2024-04-30 |
Former positions of Polly Murphy
| Companies | Position | End |
|---|---|---|
| UROGEN PHARMA LTD. | Corporate Officer/Principal | 2024-04-30 |
| PFIZER INC. | Corporate Officer/Principal | 2020-07-31 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2008-07-31 |
Training of Polly Murphy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
82
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iowa State University
 Iowa State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nova Southeastern University, Inc.
 Nova Southeastern University, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
Celcuity, Inc.
 Celcuity, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company develops novel diagnostic tests | Health Technology |
Avadel Pharmaceuticals Plc
 Avadel Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Polly Murphy
